Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05985642 · ClinicalTrials.gov registry record

Observational PIC Destination Cohort

A clinical trial of HIV-1-infection, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Recruiting
Registry status
30
Enrollment target
4
Study locations

NCT05985642 is a study of HIV-1-infection that is actively recruiting participants, run by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections. The registered enrollment target is 30 participants, below the 351-participant average among 71 other HIV-1-infection trials with a reported enrollment target (91% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05985642, a study of HIV-1-infection, is actively recruiting participants, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

RECRUITING
Registry status
30 participants
Enrollment target
4
Study locations

Study Summary

This study is being done to see if people who control HIV without antiretroviral therapy (ART) after receiving an intervention can remain off ART safely. The information collected in this study is also being used to try to understand how people control HIV without ART after receiving an intervention.

Conditions Studied

HIV-1-infection

Study Locations (4)

California

  • University of California, San Francisco HIV/AIDS CRS (801) - San Francisco

Missouri

  • Washington University Therapeutics (WT) CRS (2101) - St Louis

New York

  • Weill Cornell Upton CRS (7803) - New York

Ohio

  • Case CRS (2501) - Cleveland

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-03-19
Est. Completion 2029-09-03

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

45 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05985642

The ClinicalTrials.gov registry entry for NCT05985642 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 351-participant average among 71 other HIV-1-infection trials with a reported enrollment target (91% lower). The listed sponsor is Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV-1-infection appearing as the primary indexed condition, and to 0 interventions.

NCT05985642 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Missouri, New York.

Frequently Asked Questions

What is clinical trial NCT05985642 about?

NCT05985642 is a clinical study titled "Observational PIC Destination Cohort". This study is being done to see if people who control HIV without antiretroviral therapy (ART) after receiving an intervention can remain off ART safely. The information collected in this study is also being used to try to understand how people control HIV without ART after receiving an intervention...

What is the current status of trial NCT05985642?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2024-03-19. Estimated completion is 2029-09-03.

What conditions does trial NCT05985642 study?

This clinical trial studies the following conditions: HIV-1-infection.

Who is sponsoring clinical trial NCT05985642?

This trial is sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05985642 being conducted?

This trial has 4 study locations across California, Missouri, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV-1-infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV-1-infection

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.